# GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis Post-Market Clinical Follow-Up (PMCF) Observational Registry

> **NCT07279649** · — · NOT_YET_RECRUITING · sponsor: **W.L.Gore & Associates** · enrollment: 240 (estimated)

## Conditions studied

- Aorto-iliac Occlusive Disease (AIOD)
- Visceral Artery Occlusive Disease (VAOD)
- Isolated Artery Aneurysms (IAA)
- Trauma or Iatrogenic Vessel Injury

## Interventions

- **DEVICE:** Reduced Profile GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis (Reduced Profile VBX Stent Graft-BXB)

## Key facts

- **NCT ID:** NCT07279649
- **Lead sponsor:** W.L.Gore & Associates
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06
- **Primary completion:** 2031-01
- **Final completion:** 2031-01
- **Target enrollment:** 240 (ESTIMATED)
- **Last updated:** 2026-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07279649

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07279649, "GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis Post-Market Clinical Follow-Up (PMCF) Observational Registry". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07279649. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*